Conceivable Life Sciences Overview
- Year Founded
-
2022
- Status
-
Private
- Employees
-
48
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$50.5M
- Investors
-
13
Conceivable Life Sciences General Information
Description
Developer of a fully automated AI-powered IVF lab designed to improve precision, quality, and scalability in fertility treatments. The company offers an integrated platform that handles all IVF lab functions, including sperm processing, egg preparation, and incubation, enabling individuals facing infertility to access consistent and safer fertility care.
Contact Information
Website
www.conceivable.lifeCorporate Office
- 110 East 25th Stree
- New York, NY 10010
- United States
Corporate Office
- 110 East 25th Stree
- New York, NY 10010
- United States
Conceivable Life Sciences Timeline
Conceivable Life Sciences Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Early Stage VC (Series A) | 06-Aug-2025 | $50.5M | Completed | Generating Revenue | ||
| 2. Early Stage VC (Series A) | 02-Jan-2025 | Completed | Generating Revenue | |||
| 1. Seed Round | 07-Jul-2023 | $20M | $20M | Completed | Generating Revenue |
Conceivable Life Sciences Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A1 | ||||||||
| Series A2 | ||||||||
| Seed-2 | ||||||||
| Seed-1 | 1,254,048 | $0.000100 | $9.69 | $9.69 | 1x | $9.69 | 5.13% | |
| Seed | 4,500,000 | $0.000100 | $0.33 | $0.33 | 1x | $0.33 | 18.41% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Conceivable Life Sciences Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Conceivable Life Sciences Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Conceivable Life Sciences Investors (13)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Advance Venture Partners | Venture Capital | Minority | ||
| Atlantic Health System | Corporation | Minority | ||
| Scrub Capital | Venture Capital | Minority | ||
| ARTIS (San Francisco) | Venture Capital | Minority | ||
| Atlantic Health Venture Studio | Accelerator/Incubator | Minority |
Conceivable Life Sciences Investments (1)
Conceivable Life Sciences’s most recent deal was a Corporate with IVF 2.0 for . The deal was made on 01-Dec-2022.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| IVF 2.0 | 01-Dec-2022 | Corporate | Enterprise Systems (Healthcare) |
Conceivable Life Sciences FAQs
-
When was Conceivable Life Sciences founded?
Conceivable Life Sciences was founded in 2022.
-
Where is Conceivable Life Sciences headquartered?
Conceivable Life Sciences is headquartered in New York, NY.
-
What is the size of Conceivable Life Sciences?
Conceivable Life Sciences has 48 total employees.
-
What industry is Conceivable Life Sciences in?
Conceivable Life Sciences’s primary industry is Laboratory Services (Healthcare).
-
Is Conceivable Life Sciences a private or public company?
Conceivable Life Sciences is a Private company.
-
What is the current valuation of Conceivable Life Sciences?
The current valuation of Conceivable Life Sciences is .
-
What is Conceivable Life Sciences’s current revenue?
The current revenue for Conceivable Life Sciences is .
-
How much funding has Conceivable Life Sciences raised over time?
Conceivable Life Sciences has raised $88.5M.
-
Who are Conceivable Life Sciences’s investors?
Advance Venture Partners, Atlantic Health System, Scrub Capital, ARTIS (San Francisco), and Atlantic Health Venture Studio are 5 of 13 investors who have invested in Conceivable Life Sciences.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
